Design of Nanostructures for Theranostics Applications Pharmaceutical Nanotechnology Series
Coordonnateur : Grumezescu Alexandru Mihai
Design of Nanostructures for Theranostics Applications focuses on the theranostics applications of nanostructures. In particular, multifunctional nanoparticles for diagnostics and treatment of different diseases, including those relating to the blood-brain barrier, are discussed in detail. Chapters explore different type of nanostructures, covering design, fabrication, functionalization and optimization, helping readers obtain the desired properties. Written by a diverse range of international academics, this book is a valuable reference resource for those working in both nanoscience and the pharmaceutical industry.
2. Trastuzumab drug delivery systems for Magnetic Resonance detection
3. A novel approach for drug targeting: core-shell type lipid-polymer hybrid nanocarriers
4. Multifunctional core-shell polymeric and hybrid nanoparticles as anticancer nanomedicines
5. Multifunctional Core Shell Nanostructures as Theranostics
6. Prospects of precision therapy and imaging of glioblastoma in vivo using quantum dots
7. Mesoporous silica nanoparticles as drug carrier for cancer therapy and bioimaging
8. Current approaches in breast cancer targeting pharmaceuticals
9. Novel multifunctional nano-carrier mediated co-delivery for targeting and treatment of prostate cancer
10. Nanoparticles and their promising applications in therapeutics and diagnostics of various neurological disorders
11. Conventional and current imaging techniques in cancer research and clinics
12. Synthetic microbial ecology and nanotechnology for production of taxol and its precursors: a step towards sustainable production of cancer therapeutics
13. Polymeric and lipid-based systems for controlled drug release: an engineering point of view
14. Mercaptosuccinic Acid Capped CdTe/CdS/ZnS nanoparticles Core-Double Shell Quantum Dots: Structural Optical Imaging and Cytotoxic Assessment on Normal and Cancer Cells
15. Quantum Dots in Pharmaceutical Sciences
16. Liposomes and Micelles as Lipid Based Nanocarriers for Diagnostic and Imaging Purposes
17/ Dendrimer-drug conjugates: synthesis, characterization and application in anticancer drug delivery
- Explores how the design of a range of nanomaterials make them effective theranostic agents, including multifunctional core-shell nanostructures, mesoporous silica nanoparticles, and quantum dots
- Shows how nanomaterials are used effectively for a range of diseases, including breast cancer, prostate cancer and neurological disorders
- Assesses the pros and cons of using different nanomaterials for different types of treatment
Date de parution : 01-2018
Ouvrage de 692 p.
19x23.3 cm
Thèmes de Design of Nanostructures for Theranostics Applications :
Mots-clés :
ASO; Analytical characterization; Anatomical; Anti-tumor efficacy; Anticancer drugs; Aptamer; Biodegradable polymeric nanoparticles; Biomarker; Biomedical imaging; Biosensors; Block copolymer core-shell nanoparticles; Breast cancer; CRISPR; CRISPRa; CRISPRi; CRISPRn; CT; Cancer; Cancer cells; Cancer diagnostics; Cancer immunotherapy; Cancer theranostics; Cancer therapeutics; Cancer treatment; Cardiovascular diseases; Cas1; Cas2; Cas9; Chemotherapeutics; Controlled release; DCas9; Degradation; Dendrimer-drug conjugate; Dendrimers; Determination; Diagnosis; Drug delivery system; Drug delivery systems; Drug treatment; Epigenome therapy; Functional; Gene; Genomics; Gold; Green cage nanoparticles; Her2; Hormonal therapy; Hybrid systems; Imaging; Iron; Lipid-polymer hybrid nanoparticles; Lipopolyplexes; Liposomes; Lung cancer; MCM-41; MRI; MRS; Magnetic affinity beads; Mammography; Melanoma; Mesoporous silica; Metal-organic framework nanoparticles; MiRNA; Micelles; Molecular imaging; Monoclonal antibody; Multistage targeting; Nanocarriers; Nanochips; Nanodevices; Nanomedicine; Nanoneuromedicine; Nanoparticle; Nanoparticles; Nanotechnology; Nanotheranostics; Nanotoxicity; Oncology; PET; Photothermal and hyperthermia; Plastic surgery robotic therapy; Polymer-lipid hybrid core-shell nanoparticles; Polymer-polypeptide hybrid core-shell nanoparticles; Prevention; Prognosis; Prostate cancer; Proteomics; RNAi; SBA-15; SPECT; Self-assembly; ShRNA; SiRNA; Silver; Small RNA; Smart drug delivery carriers; Stability; Stimuli-responsive nanogels; Surface modification; Surgery